It is well known that mast cells are derived from hematopoietic stem cells. However, in adult hematopoiesis, a committed mast cell progenitor has not yet been identified in any species, nor is it clear at what point during adult hematopoiesis commitment to the mast cell lineage occurs. We identified a cell population in adult mouse bone marrow, characterized as Lin ؊ c-Kit ؉ Sca-1 ؊ -Ly6c ؊ FcRI␣ ؊ CD27 ؊ ␤7 ؉ T1͞ST2 ؉ , that gives rise only to mast cells in culture and that can reconstitute the mast cell compartment when transferred into c-kit mutant mast cell-deficient mice. In addition, our experiments strongly suggest that these adult mast cell progenitors are derived directly from multipotential progenitors instead of, as previously proposed, common myeloid progenitors or granulocyte͞macrophage progenitors.
It is well known that mast cells are derived from hematopoietic stem cells. However, in adult hematopoiesis, a committed mast cell progenitor has not yet been identified in any species, nor is it clear at what point during adult hematopoiesis commitment to the mast cell lineage occurs. We identified a cell population in adult mouse bone marrow, characterized as Lin ؊ c-Kit ؉ Sca-1 ؊ -Ly6c ؊ FcRI␣ ؊ CD27 ؊ ␤7 ؉ T1͞ST2 ؉ , that gives rise only to mast cells in culture and that can reconstitute the mast cell compartment when transferred into c-kit mutant mast cell-deficient mice. In addition, our experiments strongly suggest that these adult mast cell progenitors are derived directly from multipotential progenitors instead of, as previously proposed, common myeloid progenitors or granulocyte͞macrophage progenitors.
hematopoietic stem cell ͉ multipotential progenitor M ast cells are present in adult mammals in virtually all vascularized tissues (1, 2) . Mast cells express on their surface the high-affinity receptor for IgE (i.e., FcRI) and can be activated by IgE and specific antigen to release a diverse array of mediators, including histamine, leukotrienes, prostaglandins, serine proteases, and various cytokines, chemokines, and growth factors (2) (3) (4) . Accordingly, mast cells are known primarily as critical effector cells of asthma and other IgE-associated allergic disorders (2) (3) (4) . However, mast cells can be activated by many mechanisms in addition to IgE and specific antigen, and these cells have also been implicated in the pathogenesis of autoimmune disorders (5) , in the expression of innate immunity to bacterial infection (6, 7) , and in a wide variety of other biological processes (1) (2) (3) (4) (5) (6) (7) .
It has long been known that mast cells arise from hematopoietic progenitors (8) . Moreover, by using in vitro colony forming assays and in vivo bone marrow transplantation, it has been shown that cells with mast cell-generating activity are present in the bone marrow and certain peripheral tissues (1, 8, 9) . These findings and other lines of evidence indicate that mast cells normally do not mature before leaving the bone marrow but circulate through the vascular system as immature progenitors that then complete their development peripherally within connective or mucosal tissues (1, 2, 4, 10, 11) .
However, a definite mast cell progenitor (MCP) has been identified only in fetal blood (12) . Such Thy-1 lo c-Kit hi ''promastocytes'' lack expression of FcRI but can generate FcRIexpressing functional mast cells in vitro and in vivo (12) . However, the counterpart of the promastocyte in adult-type hematopoiesis has remained elusive despite years of research. In part, the difficulty in isolating the MCP may reflect important differences between fetal and adult hematopoiesis. These processes have some broad similarities but also exhibit intrinsic differences in hematopoietic progenitor cell fate potentials, proliferation capacity, colony-forming activity, and differentiation fidelity (13) . In this study, we identified and characterized a MCP in adult mouse bone marrow and demonstrated that this adult MCP can give rise to mast cells in the tissues of c-kit mutant mast cell-deficient mice in vivo. We also provide evidence that strongly supports the hypothesis that the adult MCP can be derived directly from multipotential progenitors (MPPs). Cells Staining and Sorting. For stem cells and progenitor isolation, bone marrow cells were stained with unconjugated antibodies specific for the following lineage makers: CD3 (KT31.1), CD4 (GK1.5), CD5 (53-7.3͞7.8), CD8 (53-6.7), CD11b (M1/70), B220 (6B2), Gr-1 (8C5), and TER119. Cells were then stained with goat anti-rat IgG microbeads (Miltenyi Biotec, Auburn, CA) and passed through an LD column (Miltenyi Biotec) to remove the Lin ϩ cells. For isolation of MCPs, the remaining lineagedepleted cells were blocked with unconjugated anti-Fc␥RII͞III (2.4G2, Pharmingen). The cells were then stained with FITCconjugated anti-T1͞ST2 (DJ8, MD Biosciences, St. Paul); phycoerythrin (PE)-conjugated anti-FcRI␣ (MAR-1, eBioscience, San Diego) and anti-Ly6C (HK1.4, Southern Biotech, Birmingham, AL); PE͞Cy5-conjugated lineage-specific antibodies (eBioscience) CD3 (145-2C11), CD4, CD8, CD11b, B220, Gr-1, and TER119; Texas red-conjugated anti-Sca-1 (E13-161-7); allophycocyanin (APC)-conjugated anti-CD27 (LG.7F9, eBioscience); biotin-conjugated anti-␤7 integrin (M293, Pharmingen) [revealed by PE͞Cy7-conjugated strepavidin (Caltag, Burlingame, CA)]; and APC͞Cy7-conjugated anti-c-Kit (2B8, eBioscience). For assessing CD9 and ␤1 integrin expression levels on ␤7 ϩ progenitors, the lineage-depleted cells were stained with FITC-conjugated anti-FcRI␣ (eBioscience) and Ly6C (AL-21, Pharmingen), PE-conjugated anti-␤7 integrin (Pharmingen), PE͞Cy5-conjugated lineage-specific antibodies, Texas red-conjugated anti-Sca-1, APC-conjugated anti-CD27, APC͞Cy7-conjugated anti-c-Kit, and biotin-conjugated anti-CD9 (KMC8, Pharmingen) or anti-␤1 integrin (Ha2͞5, Pharmingen) revealed by PE͞Cy7-conjugated strepavidin. For isolation of ␤7 ϩ progenitors and other myeloid progenitors, the remaining cells were stained with FITC-conjugated anti-CD34 (RAM34, Pharmingen), PE-conjugated anti-FcRI␣, PE͞Cy5-conjugated lineage-specific antibodies, Texas red-conjugated anti-Sca-1, APC-conjugated anti-Fc␥RII͞III (93, eBioscience), biotinconjugated anti-␤7 integrin (revealed by PE͞Cy7-conjugated Abbreviations: HSC, hematopoietic stem cell; MCP, mast cell progenitor; MPP, multipotential progenitor; CMP, common myeloid progenitors; GMP, granulocyte͞macrophage progenitor; BMCMC, bone marrow-derived cultured mast cell; MEP, megakaryocyte͞ erythrocyte progenitor; PE, phycoerythrin; APC, allophycocyanin; SCF, stem cell factor; TPO, thrombopoietin; EPO, erythropoietin; GM-CSF, granulocyte͞macrophage colonystimulating factor; Flt-3L, RT-PCR Analysis. RNA (50 ng) was isolated from cells with an RNeasy mini kit (Qiagen, Valencia, CA) and converted to first-strand cDNA with oligo(dT) [12] [13] [14] [15] [16] [17] [18] primers (Promega) and Sensiscript reverse transcriptase (Qiagen) before amplification with specific primers using AccuPrime polymerase (Invitrogen). The resulting PCR products were resolved on 2% agarose gels. The primer pairs used for amplification were the following: mouse mast cell carboxypeptidase A, GCAGGCAGGCACA-GTTATG (forward) and TGTTGGTGTTTGGAGAAGAGTC (reverse); mast cell protease-2, TTGTTCACCCAAAGTT-TCAG (forward) and CCTGGAGTTGATAATCGTA-ATC (reverse); mast cell protease-4, GACAGAATCCACACAGCA-GAAG (forward) and CCTCCAGA-GTCTCCCTTGTATG (reverse); mast cell protease-6, GGGAGGACATGAGGCTTC (forward) and AGTATAGATACTGCTCACGAAG (reverse).
Materials and Methods
Immunofluorescence Microscopy. Stomach and ear pinna specimens were carefully dissected and embedded in OCT compound (Tissue Tek, Torrance, CA) for cryopresevation. For each tissue, two consecutive sections (10 m each) were cut and stained with 0.1% toluidine blue (pH 1.0) or FITC-conjugated anti-CD45.1 (A20, Phramingen) followed by Rhodamine-conjugated streptavidin (Vector Laboratories). The samples were mounted by using fluorescent mounting medium (DakoCytomation, Carpinteria, CA). Images were captured with an Olympus BX60 fluorescence microscope and BIOQUANT image analysis software (R & M Biometrics, Nashville).
Supporting Information. For more information, see Figs. 5-9, which are published as supporting information on the PNAS web site.
Results and Discussion
We began our search for adult MCPs in mouse bone marrow because this compartment contains most of the hematopoietic progenitors (Lin Ϫ c-Kit ϩ Sca-1 Ϫ ), which possess mast cellgenerating activity. However, the relatively long (4-to 8-week) culture time required for such bone marrow cells to generate essentially homogenous populations of bone marrow-derived cultured mast cells (BMCMCs) through standard culture methods represented a major limitation in the search for the MCP (15) . In our in vitro liquid culture system, we cultured sorted candidate progenitors in Iscove's modified Dulbecco's medium containing 10% FCS and cytokine mixtures. With this approach, we were able to generate mast cells within 11-14 days after culture (Fig. 5) .
To remove any mature mast cells that might contaminate candidate progenitor populations, FcRI␣ ϩ cells were excluded. We then divided the progenitor compartment into three fractions based on ␤7 integrin (␤7) [an integrin expressed on BMCMCs (11, 16) ] and CD27 [a marker for hematopoietic stem cells and progenitors (17)]. By using our liquid culture assay, we found that the majority of the mast cell-generating activity is in the ␤7 ϩ CD27 Ϫ fraction (Fig. 6 ). We then analyzed this fraction for surface expression of T1͞ST2, an orphan receptor in the IL-1 receptor family that is expressed on T helper type 2 cells and mast cells (18) (19) (20) ; CD9, a marker for megakaryocyte progenitors (21); and ␤1 integrin, another integrin expressed on BMCMCs (16) and HSCs (22) . We found that the ␤7 ϩ CD27
Ϫ progenitors can be separated into two populations based on T1͞ST2 expression (Fig. 1A) . We double-sorted the ␤7 ϩ CD27 Ϫ progenitors into T1͞ST2 ϩ and T1͞ST2 Ϫ fractions and cultured them in the presence of SCF, EPO, TPO, Flt-3L, GM-CSF, and IL-1, -3, -6, -7, -9 and -11, a cytokine mixture that allows the development of most lineages except T cells. ␤7 ϩ T1͞ST2 ϩ progenitors represented the only fraction that generated mast cells exclusively after 5 or 11 days in culture (Fig. 1B) . Cytospins of ␤7 ϩ T1͞ST2 ϩ and ␤7 ϩ T1͞ST2
Ϫ cells prepared immediately after sorting showed that they looked very similar and, in contrast to promastocytes (12), did not contain prominent cytoplasmic granules (Fig. 1C , After sort). But after 11 days in liquid culture, ␤7 ϩ T1͞ST2 ϩ progenitors give rise to pure populations of mast cells, whereas the ␤7 ϩ T1͞ST2 Ϫ fraction gave rise to mixed populations of mast cells (Fig. 1C , day 11, arrows) and macrophages (Fig. 1C, day 11, arrowheads) . In methylcellulose assays, ␤7 ϩ T1͞ST2 ϩ progenitors again generated only mast cell colonies, whereas ␤7 ϩ T1͞ST2 Ϫ cells formed mainly erythrocyte͞megakaryocyte colonies (Fig. 1D) . Notably, flow cytometry analysis of the ␤7 ϩ CD27 Ϫ fraction indicated that it contained mainly megakaryocyte͞erythrocyte progenitors (MEPs) and common myeloid progenitors (CMPs) (Fig. 7) . Based on these in vitro data, we provisionally named the ␤7 (23, 24) . After 4 weeks, no donor-derived myeloid cells or lymphoid cells were detected in the blood, spleen, peritoneal lavage fluid, or bone marrow of the MCP-transplanted animals ( Fig. 2A and data not shown) . Donor-derived peritoneal mast cells were present in MCPtransplanted animals but not in control mice that received only rescuing Kit W-sh ͞Kit W-sh bone marrow cells (Fig. 2B) . We also performed immunofluorescence microscope analysis on sections from stomach and ear pinna specimens of MCP-transplanted animals. By using rhodamine-conjugated avidin to identify mast cells and FITC-labeled anti-CD45.1 antibody to identify donorderived cells, we found only donor-derived mast cells in these tissues (i.e., the only rhodamine-conjugated avidin ϩ mast cells present were FITC-labeled anti-CD45.1 antibody ϩ ) (e.g., Fig. 2C and data not shown). Based on the intense staining of their cytoplasmic granules in toluidine blue-stained sections of forestomach and ear pinna from the MCP-transplanted Kit W-sh ͞ Kit W-sh mice, such donor-derived mast cells appeared to be rather mature by morphology (Fig. 8) . However, we found no evidence of any other donor-derived cell lineages in sections from such mice (i.e., there were no identifiable rhodamine-conjugated avidin Ϫ , FITC-labeled anti-CD45.1 antibody ϩ cells) (e.g., Fig.  2C and data not shown). Thus, MCPs can give rise to tissue mast cells in vivo. Moreover, MCPs do not appear to be able to generate any lineage other than mast cells in vivo.
After 14 days in vitro, MCP-derived cells, compared with ex vivo freshly sorted MCPs, maintained similar levels of expression of c-Kit, ␤7, and T1͞ST2 but exhibited increased expression of FcRI␣, CD13, CD34, Sca-1, and Thy-1.1 to levels comparable with or higher than those in 6-week-old IL-3-derived BMCMCs (Fig. 3A) . We also evaluated by RT-PCR the expression of mast cell-associated proteases in cultured MCPs. Whereas cultured MCPs expressed levels of mRNA for mouse mast cell carboxypeptidase A, which were similar to those in standard IL-3-derived BMCMCs, the levels of expression of mRNA for mouse mast cell protease-2, -4, and, -6 were higher in cultured MCPs than in BMCMCs. This result may reflect differences in the cytokine mixtures in the two culture conditions: That for MCPs contains IL-9, which can up-regulate mouse mast cell protease-2 and -4 (25); SCF, which can up-regulate mouse mast cell protease-4 and -6 (26); and IL-3, which is used to generate BMCMCs (15, 27) .
The developmental relationship of mast cells to other myeloid cells has yet to be fully resolved. It had been proposed that CMPs can give rise to all myeloid cells, including mast cells (28) . Although we are not aware of actual data to support this claim, mast cells do express transcription factors required for granulocyte͞macrophage lineage development, such as PU.1 (29) , and share the expression of GATA-1 and GATA-2 with erythrocyte͞ megakaryocyte lineage cells (30) . Indeed, PU.1 and GATA-2 are required for normal mast cell development (31) . These findings suggest a close developmental relationship between mast cells and these two other lineages.
To investigate the developmental relationship of MCPs to other myeloid progenitors, we separated the Lin Ϫ c-Kit ϩ Sca-1 Ϫ FcRI␣ Ϫ hematopoietic progenitors based on their ␤7 expression. ␤7 Ϫ cells were further sorted based on their Fc␥RII͞III and CD34 expression into CMPs, granulocyte͞ macrophage progenitor (GMPs), and MEPs (32) . These sorted populations were cultured with SCF, EPO, TPO, Flt-3L, GM-CSF, and IL-1, -3, -6, -7, -9, and -11. We found that the ␤7 ϩ progenitors were the only population that could give rise to mast cells. Under the same culture conditions, ␤7-depleted CMPs, GMPs, and MEPs did not generate mast cells, even after 11 days in culture (Fig. 4A) .
In addition, we performed two experiments in which Lin Ϫ c-
Ϫ hematopoietic progenitors were further sorted based on their Fc␥RII͞III and CD34 expression into CMPs, GMPs and MEPs, and then cultured with SCF, EPO, TPO, Flt-3L, GM-CSF and IL-1, -3, -6, -7, -9, and -11 for 5 or 11 days. Little or no mast cell-generating potential was detected in any of the three populations (Fig. 9) . In each experiment, a few mast cells arose from the population of ␤7 ϩ T1͞ST2 Ϫ GMPs. However, the mast cell-generating potential of this population was very modest compared with that of MCPs (Fig. 1 A) . Accordingly, we think that the results shown in Fig. 9 (33) . The cells were labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE) so that cell division could be traced (34) , and the cells were cultured with SCF and IL-3, -6, and -9, a cytokine mixture that can more specifically stimulate the growth of mast cells. After 5 days in culture, a c-Kit ϩ FcRI␣ ϩ immature mast cell population was present in cultures derived from all three fractions. The percentage of the immature mast cell population and their c-Kit and FcRI␣ expression increased as HSCs lost self-renewal capacity (Fig. 4B Center) . CFSE analysis demonstrated that LT-HSCs and ST-HSCs require more cell divisions than do these MPPs to generate this immature mast cell population. Indeed, some cells derived from MPPs do not even require a single cell division before they express the FcRI␣ (Fig. 4B Right, white arrow) . Cytospins of the sorted c-Kit ϩ FcRI␣ ϩ cells indicated that this population had the morphology of mast cells, but without as fully developed a complement of cytoplasmic granules as is present in more mature mast cells (Fig. 4B, Right Inset) . These data strongly suggest that a common progenitor for mast cells and other myeloid cells exists in the MPP compartment (Fig. 4C) . It should be noted that this compartment is heterogeneous and contains cells that have different efficiencies at producing platelets and erythrocytes (33, 35, 36) . Isolation of the MCP resolves the long-standing debate about whether there is a true mast cell-committed progenitor in adult hematopoiesis. Taken together, our findings also strongly support the hypothesis that mast cells are derived from a branch in the pathway of adult hematopoiesis that is distinct from those giving rise to the CMP or the common lymphoid progenitor (CLP) (arrow from MPP to MCP in Fig. 4C ). Indeed, we consistently failed to detect mast cell generating potential in either ␤7
Ϫ CMPs (Fig. 4A) or ␤7 ϩ CMPs (Fig. 9) . The observation that the development of some mast cells from MPPs does not require even a single cell division represents additional evidence for the direct generation of mast cells from MPPs.
However, we cannot formally rule out the possibility that MCPs (which are ␤7 ϩ T1͞ST2 ϩ ) are derived from a small subpopulation of ␤7 ϩ T1͞ST2 Ϫ cells that are found within the major ␤7 ϩ CMP population that gives rise to few or no mast cells when cultured en masse for 5 or 11 days in vitro (Fig. 9 ). This possibility is indicated by the dotted arrow from CMP to MCP in Fig. 4C . Alternatively, a common progenitor derived from the MPP might give rise to MCPs and CMPs. Either of these possibilities could account for the ability of a population of ␤7 ϩ CD27 Ϫ T1͞ST2 Ϫ progenitors to generate a few mast cell colonies in addition to other lineages of hematopoietic cells (e.g., Fig. 1 C and D) . However, we think that it is more likely that the ex istence of mast cell-generating capacity within the ␤7 ϩ CD27 Ϫ T1͞ST2 -progenitor population simply reflects contamination of this population with a few ␤7 ϩ CD27 Ϫ T1͞ST2 ϩ
MCPs
. Establishing the precise relationship among MPPs, CMPs, and MCPs may require the identification of additional surface markers to better define these three populations. However, our identification of the adult MCP will facilitate the investigation of many other important questions. These questions include the identification of candidate genes involved in mast cell commitment and the investigation of their functions by manipulating such genes in MCPs for functional analysis; a more precise determination of the lineage relationship of mast cells to other hematopoietic cells types, including basophils and eosinophils; and the tracking of MCPs during their migration, tissue invasion, and maturation, both physiologically and in settings such as parasite infections, allergic diseases, and other pathological processes. Finally, the finding that HSCs can quickly develop into mast cells raises the possibility that circulating HSCs may also serve as a source of recruited mast cell precursors during infectious challenges or in other settings. 
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